This randomized clinical trial examines the effectiveness of mobile chat messaging vs generic text messaging for relapse prevention among individuals who recently quit smoking and had abstained for 3 to 30 days.
JAMA Internal Medicine published a clinical update in Research Highlights on 01 Mar 2026.
The item focuses on Mobile Chat Messaging for Smoking Relapse Prevention.
Review the original article for the full source wording and details.